Skip to main content

and
  1. Article

    Eculizumab treatment of atypical haemolytic uraemic syndrome: results from the largest prospective clinical trial to date

    LE weekers, JM Campistol, M Espinosa, AO Gaber, J Menne, E Minetti in Critical Care (2014)

  2. Article

    Open Access

    Risk of Kaposi's sarcoma and of other cancers in Italian renal transplant patients

    A follow-up study of 1844 renal transplant patients in Italy showed a 113-fold increased risk for Kaposi's sarcoma. Kaposi's sarcoma risk was higher in persons born in southern than in northern Italy. Signific...

    D Serraino, P Piselli, C Angeletti, E Minetti, A Pozzetto in British Journal of Cancer (2005)

  3. No Access

    Chapter

    Second Renal Allograft Transplants. Experience at a Single Institution

    Registry data of heart and liver retransplantation have revealed a pattern of patient survival that is significantly worse than results achieved by primary transplantation. To verify the trend of graft surviva...

    C. V. Sansalone, G. Colella, P. Aseni, A. Meroni, G. F. Rondinara in Retransplantation (1997)

  4. No Access

    Chapter

    Cyclosporine Effect on Corticoresistant Nephrotic Syndrome in Primary Glomerulonephritis

    Cyclosporine (CsA) efficacy in nephrotic syndrome (NS) from primary glomerulonephritis (GN) other than minimal changes GN is still controversial (1); moreover CsA has been generally employed at high doses and ...

    R. Confalonieri, L. Radaelli, G. Civati, E. Minetti in Current Therapy in Nephrology (1989)

  5. No Access

    Chapter

    Renal amyloidosis — Retrospective collaborative study

    The kidney frequently contains amyloid deposits in the so-called ‘imunocyte dyscrasia-associated systemic amyloidosis’ (IDSA) and renal abnormality is the main presenting feature in most patients [1]. In the l...

    G. Banfi, M. Moriggi, R. Confalonieri, E. Minetti in The Kidney in Plasma Cell Dyscrasias (1988)